155 related articles for article (PubMed ID: 37801533)
1. Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic.
Borash J; Bunick CG; Graber E
J Drugs Dermatol; 2023 Oct; 22(10):1061. PubMed ID: 37801533
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline.
Graber E; Kay CR
J Drugs Dermatol; 2021 Jan; 20(1):98-100. PubMed ID: 33400418
[TBL] [Abstract][Full Text] [Related]
3. Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.
Grada A; Ghannoum MA; Bunick CG
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740129
[TBL] [Abstract][Full Text] [Related]
4. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
Armstrong AW; Hekmatjah J; Kircik LH
J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions.
Schachner LA; Torrelo A; Grada A; Micali G; Kwong PC; Scott GB; Benjamin L; Gonzalez ME; Andriessen A; Eberlein T; Eichenfield LF
J Drugs Dermatol; 2020 Mar; 19(3):281-290. PubMed ID: 32550690
[TBL] [Abstract][Full Text] [Related]
6. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
[TBL] [Abstract][Full Text] [Related]
7. Sarecycline Review.
Haidari W; Bruinsma R; Cardenas-de la Garza JA; Feldman SR
Ann Pharmacother; 2020 Feb; 54(2):164-170. PubMed ID: 31462063
[No Abstract] [Full Text] [Related]
8. Treatment of Impetigo and Antimicrobial Resistance.
Schachner LA; Lynde CW; Kircik LH; Torrelo A; Hohl D; Kwong P; Oza V; Andriessen A; Hebert AA
J Drugs Dermatol; 2021 Apr; 20(4):366-372. PubMed ID: 33852242
[TBL] [Abstract][Full Text] [Related]
9. Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials.
Del Rosso JQ; Stein Gold L; Baldwin H; Harper JC; Zeichner J; Obagi S; Graber E; Jimenez X; Vicente FH; Grada A
J Drugs Dermatol; 2021 Jun; 20(6):634-640. PubMed ID: 34076386
[TBL] [Abstract][Full Text] [Related]
10. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
Zhanel G; Critchley I; Lin LY; Alvandi N
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
[TBL] [Abstract][Full Text] [Related]
11. Sarecycline hydrochloride for the treatment of acne vulgaris.
Kaul G; Saxena D; Dasgupta A; Chopra S
Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559
[TBL] [Abstract][Full Text] [Related]
12. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
[TBL] [Abstract][Full Text] [Related]
13. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris.
Valente Duarte de Sousa IC
Expert Opin Pharmacother; 2021 Feb; 22(2):145-154. PubMed ID: 32924666
[TBL] [Abstract][Full Text] [Related]
14. The Microbiome and Antimicrobial Stewardship in Surgical Patients.
Creel JP; Maves RC
Surg Infect (Larchmt); 2023 Apr; 24(3):220-225. PubMed ID: 37010965
[No Abstract] [Full Text] [Related]
15. Antibiotic stewardship and empirical antibiotic treatment: How can they get along?
Zuccaro V; Columpsi P; Sacchi P; LucĂ MG; Fagiuoli S; Bruno R
Dig Liver Dis; 2017 Jun; 49(6):579-584. PubMed ID: 28215515
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A
J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451
[TBL] [Abstract][Full Text] [Related]
17. Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship.
Kaupitwa CJ; Nowaseb S; Godman B; Kibuule D
Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1365-1379. PubMed ID: 35912881
[TBL] [Abstract][Full Text] [Related]
18. Preparing for the New Joint Commission Requirements: a Model for Tracking Outcomes of an Ambulatory Antibiotic Stewardship Program in Primary Care.
Hempel EV; Duca N; Kipp R; van Harskamp J; Caputo G
J Gen Intern Med; 2021 Mar; 36(3):762-766. PubMed ID: 33420558
[TBL] [Abstract][Full Text] [Related]
19. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.
Batool Z; Lomakin IB; Polikanov YS; Bunick CG
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463
[TBL] [Abstract][Full Text] [Related]
20. The Infusion Nurse's Role in Antibiotic Stewardship.
Morgan SA
J Infus Nurs; 2019; 42(2):75-80. PubMed ID: 30817423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]